{"id":"https://openalex.org/W3111891301","doi":null,"title":"Akt and p38 MAPK synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells","display_name":"Akt and p38 MAPK synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W3111891301","mag":"3111891301"},"language":"en","primary_location":{"id":"mag:3111891301","doi":null,"is_oa":false,"landing_page_url":"https://oak.novartis.com/8102/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055853326","display_name":"Ellen Weisberg","orcid":"https://orcid.org/0000-0002-5679-9531","observed_orcids":["https://orcid.org/0000-0002-5679-9531"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ellen Weisberg","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5679-9531","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112066295","display_name":"Qingsong Liu","orcid":"https://orcid.org/0000-0002-7829-2547","observed_orcids":["https://orcid.org/0000-0002-7829-2547","https://orcid.org/0000-0001-9513-3591","https://orcid.org/0000-0003-1858-1504"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qingsong Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7829-2547","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100327547","display_name":"Xin Zhang","orcid":"https://orcid.org/0000-0002-9876-7829","observed_orcids":["https://orcid.org/0000-0002-9876-7829"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xin Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9876-7829","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Eric J. Nelson","orcid":"https://orcid.org/0000-0003-2649-2624","observed_orcids":["https://orcid.org/0000-0003-2649-2624"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric J. Nelson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2649-2624","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034151974","display_name":"Martin Sattler","orcid":"https://orcid.org/0000-0001-5053-4199","observed_orcids":["https://orcid.org/0000-0001-5053-4199"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Sattler","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5053-4199","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101872276","display_name":"Feiyang Liu","orcid":"https://orcid.org/0000-0002-0228-4567","observed_orcids":["https://orcid.org/0000-0002-0228-4567"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Feiyang Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0228-4567","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055491236","display_name":"Maria Nicolais","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Nicolais","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100427561","display_name":"Jianming Zhang","orcid":"https://orcid.org/0000-0001-6326-3906","observed_orcids":["https://orcid.org/0000-0001-6326-3906"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jianming Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6326-3906","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012712111","display_name":"Constantine S. Mitsiades","orcid":"https://orcid.org/0000-0003-2321-8005","observed_orcids":["https://orcid.org/0000-0003-2321-8005"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Constantine S. Mitsiades","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2321-8005","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074875514","display_name":"R Smith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071023119","display_name":"Richard Maury Stone","orcid":"https://orcid.org/0000-0002-7526-2633","observed_orcids":["https://orcid.org/0000-0002-7526-2633"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard M. Stone","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7526-2633","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051795460","display_name":"Ilene A Galinsky","orcid":"https://orcid.org/0000-0002-9158-5061","observed_orcids":["https://orcid.org/0000-0002-9158-5061"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ilene Galinsky","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9158-5061","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047404508","display_name":"Atsushi Nonami","orcid":"https://orcid.org/0009-0001-8153-7082","observed_orcids":["https://orcid.org/0009-0001-8153-7082"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Atsushi Nonami","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007667620","display_name":"D. James Griffin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. James Griffin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022352605","display_name":"Nathanael S. Gray","orcid":"https://orcid.org/0000-0001-5354-7403","observed_orcids":["https://orcid.org/0000-0001-5354-7403"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nathanael S. Gray","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5354-7403","affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Yael Carmeli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yael Carmeli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.45390473,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9850000143051147},{"id":"https://openalex.org/keywords/bone-marrow-stroma","display_name":"bone marrow stroma","score":0.6420000195503235},{"id":"https://openalex.org/keywords/akt","display_name":"Akt","score":0.703000009059906},{"id":"https://openalex.org/keywords/p38-mapk","display_name":"p38 MAPK","score":1.0},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6150000095367432},{"id":"https://openalex.org/keywords/chemical-screen","display_name":"chemical screen","score":0.6980000138282776},{"id":"https://openalex.org/keywords/synergistic-effect","display_name":"synergistic effect","score":0.4309999942779541},{"id":"https://openalex.org/keywords/midostaurin","display_name":"midostaurin","score":0.781000018119812},{"id":"https://openalex.org/keywords/ac220","display_name":"AC220","score":0.9559999704360962},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.7982286214828491},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.76380854845047},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6983439326286316},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6393002867698669},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5767184495925903},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5528886318206787},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.44420450925827026},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.4379892349243164},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.42747071385383606},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4200618863105774},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.365088552236557},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.35135865211486816},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34565144777297974},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.339516818523407},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29400670528411865},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.27006229758262634},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12685519456863403},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.04888007044792175}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3111891301","doi":null,"is_oa":false,"landing_page_url":"https://oak.novartis.com/8102/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9779000282287598,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2092815384","https://openalex.org/W1983420428","https://openalex.org/W2047406713","https://openalex.org/W3025217734","https://openalex.org/W2764314945","https://openalex.org/W2941895388","https://openalex.org/W4230452871","https://openalex.org/W3178396731","https://openalex.org/W2994038994","https://openalex.org/W2955381543"],"abstract_inverted_index":{"Tyrosine":[0],"kinase":[1,66,208],"inhibitor":[2,161],"(TKI)-treated":[3],"acute":[4,202],"myeloid":[5,203],"leukemia":[6,174],"(AML)":[7],"patients":[8],"commonly":[9],"show":[10],"rapid":[11],"and":[12,32,92,104,120,134,156,176,182],"significant":[13],"peripheral":[14],"blood":[15],"blast":[16],"cell":[17,42],"reduction,":[18],"however":[19],"a":[20,29,37,49,59],"marginal":[21],"decrease":[22],"in":[23,99,109,112,141,173],"bone":[24],"marrow":[25],"blasts.":[26],"This":[27],"suggests":[28,131],"protective":[30],"environment":[31],"highlights":[33],"the":[34,56,71,85,166,184,187],"need":[35],"for":[36,58],"greater":[38],"understanding":[39],"of":[40,69,74,87,90,95,125,144,169,179,186],"stromal:leukemia":[41],"communication.":[43],"To":[44],"address":[45],"this,":[46],"we":[47],"used":[48],"novel":[50,65],"adherent":[51,77],"stroma-based":[52],"co-culture":[53,188],"system":[54],"as":[55],"foundation":[57],"chemical":[60,189],"screen":[61,130,190],"designed":[62],"to":[63,84,106,152,191,195],"identify":[64,192],"inhibitors":[67,89],"capable":[68],"potentiating":[70],"apoptosis-inducing":[72],"effects":[73],"TKIs":[75],"against":[76],"stroma-protected":[78],"mutant":[79,126],"FLT3-positive":[80],"cells.":[81,146],"Screenings":[82],"led":[83],"identification":[86],"selective":[88],"Akt":[91,121,133,155],"MAPK,":[93,214],"mediators":[94],"signaling":[96,171],"pathways":[97],"implicated":[98],"TKI":[100,197],"exposure-induced":[101],"drug":[102],"resistance,":[103],"found":[105],"be":[107],"activated":[108],"stromal":[110,142,177],"cells":[111],"direct":[113],"contact":[114],"with":[115],"leukemia.":[116],"Although":[117],"constitutive":[118],"MAPK":[119,135,157],"activation":[122],"is":[123,150],"characteristic":[124],"FLT3-transformed":[127],"cells,":[128],"our":[129],"that":[132],"may":[136],"play":[137],"an":[138],"unexpected":[139],"role":[140],"protection":[143,178],"TKI-treated":[145,180],"In":[147],"addition,":[148],"it":[149],"common":[151],"observe":[153],"residual":[154],"activity":[158],"following":[159],"FLT3":[160,205],"treatment.":[162],"Our":[163],"findings":[164],"highlight":[165],"potential":[167],"importance":[168],"these":[170],"factors":[172],"survival":[175],"leukemia,":[181,204],"support":[183],"use":[185],"agents":[193],"able":[194],"potentiate":[196],"anti-leukemia":[198],"activity.":[199],"\r\n\r\nKey":[200],"words:":[201],"inhibitor,":[206,209],"multi-targeted":[207],"PKC412,":[210],"AC220,":[211],"Akt,":[212],"p38":[213],"stromal-mediated":[215],"chemoresistance,":[216],"synergy":[217]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2020-12-21T00:00:00"}